4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
CA 2446331 A1 · Owner: Brown, William · Inventors: Wei, Zhongyong; Brown, William; Walpole, Christopher
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds of general formula I R1 is selected from any one of phenyl pyridinyl, pyrrolyl, thienyl, furanyl, imidazolyl triazolyl, thiazolyl, and , pyridine N-oxide; where each R1 phenyl ring and R1 heteroaromatic ring may optionally and independently be further substituted by 1 2 or 3 substituents , selected from straight and branched C1-C6 alkyl NO2, CF3, C1-C6 alkoxy, chloro, fluoro bromo, and iodo. The substitutions on the phenyl ring and on the heteroaromatic ring may take place in any position on said ring systems;are disclosed and claimed in the present application as well as salts , and pharmaceutical compositions comprising the novel compounds and their use in therapy, in …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 16, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 16, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 16, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.